Citation tools
"DOT1L Inhibitor EPZ-5676 Displays Synergistic Antiproliferative Activity in Combination with Standard of Care Drugs and Hypomethylating Agents in MLL-Rearranged Leukemia Cells." Journal of Pharmacology and Experimental Therapeutics
350.3
(2014):
646-656.
Web. 18 April. 2024.